Award recordCONTRACT

GOVERNMENT SCIENTIFIC SOURCE INC

PIID 36C26323P0881· VHA· NETWORK CONTRACT OFFICE 23 (36C263)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2023· $682,756 net obligations· UEI J49CN39QTNW3· VA

Description

EO 14398

Base award description: TUBERCULOSIS REAGENTS

First action · last action
2023-08-14 · 2026-06-25
Transactions
14
First transaction's obligation
$118,386
Base + all options value (sum of deltas)
$1,231,018
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
1
SDVOSB flag on record
No
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING

Modification chain · 14 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$682,756$0Base award · 2023-08-14 · this action $118,386 · running total $118,386Modification P00001 · 2023-10-01 · this action $352,187 · running total $470,573Modification P00002 · 2023-11-27 · this action $0 · running total $470,573Modification P00003 · 2023-11-29 · this action -$77,391 · running total $393,182Modification P00004 · 2024-02-23 · this action $30,454 · running total $423,636Modification P00005 · 2024-04-01 · this action -$15,240 · running total $408,396Modification P00006 · 2024-07-09 · this action -$125,802 · running total $282,594Modification P00007 · 2024-10-01 · this action $327,320 · running total $609,914Modification P00008 · 2024-11-18 · this action -$1,008 · running total $608,906Modification P00009 · 2025-06-05 · this action -$143,169 · running total $465,736Modification P00010 · 2025-08-28 · this action $0 · running total $465,736Modification P00011 · 2025-10-01 · this action $217,020 · running total $682,756Modification P00012 · 2026-02-19 · this action $0 · running total $682,756Modification P00013 · 2026-06-25 · this action $0 · running total $682,756
  • Base2023-08-14+$118,386= $118,386
  • Mod P000012023-10-01+$352,187= $470,573
  • Mod P000022023-11-27+$0= $470,573
  • Mod P000032023-11-29-$77,391= $393,182
  • Mod P000042024-02-23+$30,454= $423,636
  • Mod P000052024-04-01-$15,240= $408,396
  • Mod P000062024-07-09-$125,802= $282,594
  • Mod P000072024-10-01+$327,320= $609,914
  • Mod P000082024-11-18-$1,008= $608,906
  • Mod P000092025-06-05-$143,169= $465,736
  • Mod P000102025-08-28+$0= $465,736
  • Mod P000112025-10-01+$217,020= $682,756
  • Mod P000122026-02-19+$0= $682,756
  • Mod P000132026-06-25+$0= $682,756
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-08-14+$118,386$118,386TUBERCULOSIS REAGENTS
Mod P00001· EXERCISE AN OPTION2023-10-01+$352,187$470,573TUBERCULOSIS REAGENTS
Mod P00002· OTHER ADMINISTRATIVE ACTION2023-11-27+$0$470,573TUBERCULOSIS REAGENTS
Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-11-29−$77,391$393,182TUBERCULOSIS REAGENTS
Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-02-23+$30,454$423,636TUBERCULOSIS REAGENTS
Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-04-01−$15,240$408,396TUBERCULOSIS REAGENTS
Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-07-09−$125,802$282,594TUBERCULOSIS REAGENTS
Mod P00007· EXERCISE AN OPTION2024-10-01+$327,320$609,914TUBERCULOSIS REAGENTS
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-11-18−$1,008$608,906TUBERCULOSIS REAGENTS
Mod P00009· FUNDING ONLY ACTION2025-06-05−$143,169$465,736TUBERCULOSIS REAGENTS - MID-YEAR DEOBLIGATION OF EXCESS FUNDS FROM OY2.
Mod P00010· EXERCISE AN OPTION2025-08-28+$0$465,736TUBERCULOSIS REAGENTS - MID-YEAR DEOBLIGATION OF EXCESS FUNDS FROM OY2.
Mod P00011· OTHER ADMINISTRATIVE ACTION2025-10-01+$217,020$682,756TUBERCULOSIS REAGENTS - MID-YEAR DEOBLIGATION OF EXCESS FUNDS FROM OY2.
Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-02-19+$0$682,756TUBERCULOSIS REAGENTS - MID-YEAR DEOBLIGATION OF EXCESS FUNDS FROM OY2.
Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-06-25+$0$682,756EO 14398

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI J49CN39QTNW3)

AwardOffice · PSC / listingNet obligationsFY
36C24526F0387245-NETWORK CONTRACT OFFICE 5 (36C245) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$6,895FY2026
36C26226P1513262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$28,264FY2026
36C25726F0130257-NETWORK CONTRACT OFFICE 17 (36C257) · 5860 · STIMULATED COHERENT RADIATION DEVICES, COMPONENTS, AND ACCESSORIES$18,391FY2026
36C24126F0141241-NETWORK CONTRACT OFFICE 01 (36C241) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE$182,326FY2026
36C25626F0181256-NETWORK CONTRACT OFFICE 16 (36C256) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS$111,133FY2026
36C24126N0855241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$1,989FY2026

Other recipients under 6550 from NETWORK CONTRACT OFFICE 23 (36C263) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26326P0546ROCHE DIAGNOSTICS CORPORATIONNETWORK CONTRACT OFFICE 23 (36C263)$262,620FY2026
36C26326D0057PROMEGA CORPORATIONNETWORK CONTRACT OFFICE 23 (36C263)$0FY2026
36C26326N0540PROMEGA CORPORATIONNETWORK CONTRACT OFFICE 23 (36C263)$24,378FY2026
36C26326N0012BIOMERIEUX INCNETWORK CONTRACT OFFICE 23 (36C263)$70,608FY2026
36C26326N0005MICROGENICS CORPORATIONNETWORK CONTRACT OFFICE 23 (36C263)$165,318FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26323P0881_3600_-NONE-_-NONE- · retrieved 2026-09-26.